Home / Inspections / 1027351

FDA Inspection 1027351 — Grifols Biologicals LLC

Grifols Biologicals LLC — FEI 2080769

The FDA completed an inspection of Grifols Biologicals LLC on August 24, 2017 in Los Angeles, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 24, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Los Angeles, CA (United States)

Facility

Other inspections at this facility

  • 1229139 (VAI Fri May 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1105923 (VAI Thu Sep 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 944819 (VAI Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 801108 (VAI Wed Sep 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 708372 (VAI Mon Nov 22 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources